deltatrials
Recruiting PHASE4 INTERVENTIONAL 2-arm NCT07040865

Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings (IRAF-WORKUP)

Randomized, Single-Blind, Monocentric, Non-Inferiority Trial of Gadopiclenol (Vueway®) Contrast Agent Performance vs. Gadobutrol (Gadovist®) in the Workup of Incidental Renal and Adrenal Findings

Sponsor: Insel Gruppe AG, University Hospital Bern

Conditions Suspect Renal and Adrenal Imaging Findings
Interventions Gadobutrol (Gadovist/Gadavist) Gadopiclenol
Updated 2 times since 2025 Last updated: Nov 18, 2025 Started: Aug 18, 2025 Primary completion: Jun 30, 2027 Completion: Jul 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Suspect Renal and Adrenal Imaging Findings and is currently actively recruiting participants. Insel Gruppe AG, University Hospital Bern leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2025 – ~Dec 2025 · 5 months · monthly snapshotNot Yet Recruiting~Dec 2025 – present · 9 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Dec 2025 — Present [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  2. Jul 2025 — Dec 2025 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Insel Gruppe AG, University Hospital Bern
Data source: Insel Gruppe AG, University Hospital Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations